InfuSystem Holdings, Inc.
DE ˙ DB ˙ US45685K1025
7,45 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityDE:1TZ / InfuSystem Holdings, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership9,896 shares
Latest Disclosed Value $ 92,528
Jpmorgan Chase & Co reports 15.34% decrease in ownership of 1TZ / InfuSystem Holdings, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 9,896 shares of InfuSystem Holdings, Inc. (DE:1TZ) valued at $79,663 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 11,689 shares of InfuSystem Holdings, Inc.. This represents a change in shares of -15.34% during the quarter. The current value of the position is $73,725 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 9,896 -1,793 -15.34 93 -11.54 0.0000
2026-02-11 2025-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 11,689 -5,110 -30.42 105 -40.23 0.0000
2025-11-26 2025-09-30 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 16,799 15,217 961.88 174 1,833.33 0.0000
2025-11-07 2025-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 16,799 15,217 174 0.0000
2025-08-12 2025-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 1,582 -11,665 -88.06 10 -87.32 0.0000
2025-05-12 2025-03-31 13F INFUSYSTEM HLDGS COMMON 45685K102 13,247 -46,415 -77.80 71 -85.91 0.0000
2025-02-12 2024-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 59,662 44,106 283.53 504 384.62 0.0000
2024-12-26 2024-09-30 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 15,556 6,623 74.14 104 70.49 0.0000
2024-11-08 2024-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 15,556 6,623 104 0.0000
2024-12-26 2024-06-30 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 8,933 -6,803 -43.23 61 -54.48 0.0000
2024-08-12 2024-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 8,933 -6,803 61 0.0000
2024-12-26 2024-03-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 15,736 3,382 27.38 135 3.08 0.0000
2024-05-10 2024-03-31 13F INFUSYSTEM HLDGS COMMON 45685K102 15,736 3,382 135 0.0000
2024-12-26 2023-12-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 12,354 0 0.00 130 9.24 0.0000
2024-02-12 2023-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 12,354 0 130 0.0000
2023-11-14 2023-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 12,354 -1,756 -12.45 119 -11.85 0.0000
2023-08-11 2023-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 14,110 14,084 54,169.23 136 0.0000
2023-05-18 2023-03-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 26 0 0.00 0 0.0000
2023-05-11 2023-03-31 13F INFUSYSTEM HLDGS COMMON 45685K102 26 0 0 0.0000
2023-02-13 2022-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 26 0 0.00 0 0.0000
2022-11-14 2022-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 26 0 0.00 0 0.0000
2022-08-11 2022-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 26 -9,596 -99.73 0 -100.00
2022-05-11 2022-03-31 13F INFUSYSTEM HLDGS COMMON 45685K102 9,622 -15,605 -61.86 94 -78.14 0.0000
2022-02-11 2021-12-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 25,227 5,435 27.46 430 66.67 0.0000
2022-02-10 2021-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 25,227 5,435 430 0.0000
2021-11-12 2021-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 19,792 8,050 68.56 258 5.74 0.0000
2021-08-12 2021-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 11,742 -29,535 -71.55 244 -70.99 0.0000
2021-05-12 2021-03-31 13F INFUSYSTEM HLDGS COMMON 45685K102 41,277 3,595 9.54 841 18.79 0.0001
2021-02-19 2020-12-31 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 37,682 29,412 355.65 708 521.05 0.0001
2021-02-11 2020-12-31 13F INFUSYSTEM HLDGS COMMON 45685K102 37,682 29,412 708 17.5093
2020-11-12 2020-09-30 13F/A-1 INFUSYSTEM HLDGS COMMON 45685K102 8,270 2,935 55.01 114 86.89 0.0000
2020-11-12 2020-09-30 13F INFUSYSTEM HLDGS COMMON 45685K102 8,270 114
2020-08-11 2020-06-30 13F INFUSYSTEM HLDGS COMMON 45685K102 5,335 5,335 61 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.